ALZHEIMER’S & OTHER NEURO-DEGENERATIVE DISEASES
A novel biomarker for younger-onset dementia
A/Professor Muireann Irish
Brain and Mind Centre, University of Sydney
Co-Investigators : Dr Christopher Madan

Project Summary:

A diagnosis of dementia results in significant distress for the individual, their family, and wider social network, and places considerable burden on already overstretched health resources. Frontotemporal dementia (FTD) is the second most common type of presenile dementia, after Alzheimer’s disease, resulting in progressive changes in behaviour, language, and thinking.

The ideal time to treat neurodegenerative disease occurs before clinical presentation, at a point when the minimum disruption to the brain has occurred. One of the greatest challenges in clinical neurology therefore is to identify individuals most at risk of developing dementia, prior to the emergence of cognitive impairment or behavioural changes. Here, we address this research challenge by exploring potential biomarkers that allow early identification of dementia, and ensure patients gain access to appropriate disease-modifying treatments.

This research project seeks to optimize the early and accurate detection of FTD using novel neuroimaging analysis techniques. FTD is highly heritable, caused by genetic mutations in one third of cases. Using cutting-edge neuroimaging techniques, we will screen for subtle changes in the overall shape of the brain’s cortex in individuals with increased genetic risk for developing FTD. We will determine signature changes in the shape of cortical and subcortical brain structures in high-risk relative to matched low-risk individuals, and will clarify how these differences in brain structure predict subtle changes in cognition.

Our novel approach will contribute the essential information to guide the screening, clinical diagnosis, and tracking of younger-onset dementia syndromes. With Australia poised on the brink of a dementia epidemic, this project has the potential to significantly address this crucial challenge, optimising our ability to intervene effectively, and to improve the overall prognosis of the individual living with dementia.

Irish